253 results on '"Torkko, Kathleen"'
Search Results
2. MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.
3. Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancer
4. Unique macrophage phenotypes activated by BMP signaling in breast cancer bone metastases
5. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung
6. Supplementary Figure S1 from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
7. Data from Cooperative Dynamics of AR and ER Activity in Breast Cancer
8. Supplementary Table 1 from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
9. Supplemental Figure 1 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
10. Supplementary Figure Legends from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
11. Supplemental Figure Legends. from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
12. Supplementary Table 1 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
13. Data from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
14. Supplemental Figure 4 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
15. Supplementary Table S2 from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
16. Data from Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
17. Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
18. Supplementary Methods from Cooperative Dynamics of AR and ER Activity in Breast Cancer
19. Supplementary Figure Legends from Cooperative Dynamics of AR and ER Activity in Breast Cancer
20. Supplemental Figure 3 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
21. Supplementary Tables 1-3 from Cooperative Dynamics of AR and ER Activity in Breast Cancer
22. Supplemental Figure 2 from A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
23. Supplementary Data from Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
24. Supplementary Figures 1-6 from Cooperative Dynamics of AR and ER Activity in Breast Cancer
25. Supplemental Table 1 from Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer
26. Supplemental Figures S1-S11 from Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer
27. Supplementary Figure 1 from The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
28. Data from The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
29. 1448 Altered myeloid memory function by BMP signaling in breast cancer bone metastases
30. Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides
31. Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma
32. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing
33. Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study
34. Reduced Expression of GDF-15 Is Associated With Atrophic Inflammatory Lesions of the Prostate
35. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease
36. Preoperative Prediction of Unifocal, Unilateral, Margin-Negative, and Small Volume Prostate Cancer
37. p16INK4a is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia
38. Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer
39. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma
40. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers
41. Guided Imagery for Treatment (GIFT): Protocol of a Pilot Trial of Guided Imagery Versus Treatment as Usual to Address Radiotherapy-related Distress in Head and Neck Cancer
42. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
43. B7-H4 expression in Brenner tumours, a descriptive and comparative study
44. Association Between an Eestrogen Receptor Alpha Gene Polymorphism and the Risk of Prostate Cancer in Black Men
45. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy
46. Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
47. Natural History of Prostate Cancer-Epidemiologic Considerations
48. Testing for Chlamydia and Sexual History Taking in Adolescent Females: Results From a Statewide Survey of Colorado Primary Care Providers
49. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients
50. A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.